So far, the Marburg virus has killed 12 people in Rwanda since it was declared an outbreak on September 27. Talking about the source of this outbreak, authorities said that there is still no confirmation of the source of the outbreak.

Rwanda will begin vaccine trials for the fatal Marburg virus after the Ebola -like disease killed 12 people in the African country. Health minister Sabin Nsanzimana said vaccinations would focus on those most at risk of contracting the virus, including healthcare workers and close contacts of confirmed cases.

Rwanda health authorities will launch a vaccine study to counter the Marburg hemorrhagic fever outbreak, which has already claimed 12 lives. The Sabin Vaccine Institute provided 700 trial doses targeting health workers and contacts of confirmed cases.

Marburg has caused small, episodic outbreaks since first being identified, most recently last year in Tanzania and Ghana. It is one of the deadliest known viruses, with no approved vaccines or specific treatments.

What you need to know as Europe fears cases - Virus, which has similarities to Ebola, has killed at least nine people during an outbreak in Rwanda

The country has already received shipments of the vaccines including from the Sabin Vaccine Institute. Rwanda's first outbreak of the viral hemorrhagic fever was detected in late September, with 46 cases and 12 deaths reported since then. Marburg has a fatality rate as high as 88 per cent.

Rwanda has said it will begin vaccine trials for the fatal Marburg virus, which has already killed at least 12 people in the country - most of them health workers. The east African country has received 700 doses of the vaccine from the Sabin Vaccine Institute,

Government to prioritise those ‘most at risk’ and ‘most exposed healthcare workers’ following the deaths of 12 people.

Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever as the East African country tries to stop the spread of an outbreak that has killed 12 people